Description
- Taficita is a generic version of Descovy manufactured by Mylan.
- [Lowest price guarantee]
- The displayed price is in USD. It includes VAT and the shipping fee to Singapore/Thailand/Vietnam/Korea/Hong Kong/Taiwan/Japan. Shipment tracking number is provided after the shipment dispatch.
- Taficita is a fixed dose combination tablet containing emtricitabine (FTC) 200 mg and tenofovir alafenamide (TAF) 25 mg for oral administration.
- Approved by authorized institutions, including the US Food and Drug Administration (FDA).
About side effects of Truvada and Descovy
Introduction of the clinical reports about the side effects. Below shows the percentage of PrEP users after taking Truvada or Descovy.
| Truvada users | Descovy users | |
| Diarrhea | 6% | 5% |
| Nausea | 5% | 4% |
| Headache | 2% | 2% |
| Fatigue, malaise | 3% | 2% |
| Abdominal pain | 3% | 2% |
Truvada may cause bone loss in adults, and decrease bone growth in children. Although early symptoms of bone loss are rare. And also, Truvada can cause or worsen kidney problems. However, the risk seems to be very low.
As a result, it is reported that the main side effects show that there is almost no difference between the two. (Source: Table 3 Adverse Reactions (All Grades) Reported in ≥2% in Either Arm in the DISCOVER Trial of HIV-1 Uninfected Participants)
PrEP can reduce the risk of HIV infection by more than 90 percent if used properly, but is far less effective if not taken as recommended.
We recommend PrEP for people at high risk of HIV infection. In practice, this mostly applies to people who have had anal sex without a condom or been diagnosed with a sexually transmitted disease (STD) in the past six months.
Although there is less information about how effective PrEP pills are among people who inject drugs.
Undoubtedly we know that PrEP pills reduce the risk of getting HIV by at least 90% when taken as prescribed. In conclusion, we don’t recommend PrEP for people who inject drugs.
For your inquiry, please contact us.
